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Abstract 
 Postoperative nausea and vomiting (PONV) continues to occur despite medical 
advances over the years.  PONV decreases patient satisfaction, can lead to postoperative 
complications such as dehydration and suture dehiscence, and it increases hospital costs.  
Evidence in the literature suggests a preoperative risk assessment screening and prophylactic 
antiemetic administration can decrease the incidence of PONV.  The purpose of this project 
was to evaluate the effectiveness of a risk assessment tool and to determine if the tool would 
decrease the incidence of PONV.  This quality improvement project involved collecting pre-
intervention PONV data over a 6-week time period.  The pre-intervention incidence was 17% 
(n=12).  A risk assessment tool was implemented in the perioperative surgical home area of 
the hospital where presurgical telephonic assessments were completed.  Post intervention 
data was collected with regard to PONV incidence over a 6-week time period, resulting in an 
incidence of 19% (n=16).  No significant findings were established as a result from this 
quality improvement project.  It is recommended to perform a similar quality improvement 
project with a larger sample size to achieve statistical significance as well as decrease the rate 
of PONV. 
 Keywords: postoperative nausea and vomiting, Apfel’s simplified risk score, risk 
assessment tool, postoperative complications 
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Chapter 1 
Postoperative Nausea and Vomiting (PONV) occurs in 10-80% of surgical patients 
(Smith, Haas, Zepp, & Klein, 2016).  Seventy percent of those patients are assessed to be a 
high risk for PONV, which can often lead to post-surgical complications (Thomas, Maple, 
Norcross, & Muckler, 2019).  The implementation of a PONV risk prediction and 
prophylaxis protocol can be implemented to be patient specific and tailored to the patient’s 
risk factors and needs, leading to improved patient satisfaction and most importantly, a 
decrease in the incidence of PONV.   
Background 
Risk factors for PONV can be difficult to pinpoint; however, various factors have 
been identified to increase one’s risk.  Gender, age, length of surgical procedure, genetics, 
and type of anesthetic used have all been linked with PONV (Squire & Spencer, 2018).  The 
female gender carries a threefold increased risk for developing PONV (Squire & Spencer, 
2018).  Additionally, gynecological surgery itself is considered a risk factor because of both 
the female patient group and the length of surgeries (Squire & Spencer, 2018). 
Prevention of PONV post-surgery can help increase patient satisfaction, improve 
healing time, and decrease length of stay (Smith & Ruth-Sahd, 2016).  A consistent method 
to identify who is at risk for PONV can provide an effective treatment regimen.  Assessing 
patients in preadmission testing can ensure the patient is identified before the onset of 
surgery and treated respectively.  Additionally, patients who are a low risk for PONV can 
avoid exposure to antiemetic medications, which come with their own risks (Thomas, et al., 
2019). 
Risk assessment tools have been implemented in various studies to evaluate their 
effectiveness on the decrease of PONV.  In a study performed by Thomas, et al. (2019), the 
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number of prophylactic antiemetics administered increased after the implementation of the 
risk prediction and prophylaxis tool.  The incidence of PONV decreased from 32.3% to 
28.9%, while the antiemetic compliance increased from 37% pre-implementation to 61% 
postimplementation (Thomas et al., 2019).  In another study by Roberts, Barclay, and Scott 
(2010), researchers compared the use of a risk measurement tool versus anesthetists’ 
subjective patient assessment.  The risk assessment tool identified 51% of a group of 
gynecological patients were at a high risk for PONV, while the anesthetists’ assessments only 
identified 25% of the same group of patients to be at a high risk.   
Impact of PONV on Patient Care 
 PONV impacts not only patient care outcomes, but also costs to a hospital or clinical 
setting.  For those who experience PONV, these patients spend twice as long in the post 
anesthesia care unit (PACU) as compared to those who do not experience PONV (Thomas et 
al., 2019).  The delay in discharge from the PACU impacts perioperative efficiency and 
disrupts the flow of patients from the operating room to the PACU, causing delays in care 
and compromising patient safety (Thomas et al., 2019).   
 PONV can impact the patient directly by resulting in poor quality of recovery and 
postoperative complications.  Dehydration, electrolyte imbalance, pulmonary aspiration, 
suture dehiscence, and pneumothorax are all possible complications in the post-operative 
period (Smith et al., 2016 & Thomas et al., 2019).  PONV also causes anxiety for patients 
preoperatively, with patients ranking PONV as the most undesirable postoperative outcome 
(Thomas et al., 2019). 
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Gap/Purpose 
Though there is evidence that the utilization of a PONV risk prediction and 
prophylaxis protocol can be successful, there is a need to perform more quality improvement 
projects and to prove its benefits.  Because of this need, the primary investigator proposed a 
retrospective pre- and post-implementation quality improvement project.  The designated 
hospital where the project took place did not utilize a risk assessment tool in its entirety.  
Patients were being screened for gender and a history of non-smoking status, but they were 
not being screened for a history of motion sickness/history of PONV.  A thorough risk 
assessment tool addresses four predictors of PONV: female gender, history of motion 
sickness or PONV, non-smoking status, and planned use of opioids postoperatively (Apfel, 
Laara, Koivuranta, Greim, & Roewer, 1999).  Patients were not specifically asked the 
predictor of planned use of postoperative opioids, as this is a decision for providers caring for 
the patient post-surgery. 
In order to capture the risk score for PONV, the hospital created an algorithm within 
the electronic health record (EHR).  As risk factors were identified, they were entered into 
the EHR.  Because motion sickness was not being addressed within the screening phone call, 
the calculated score at the time of the prescreening phone call was incomplete.  It was 
unclear if patients were a low, moderate, or high risk for PONV at this point in the pre-
surgery screening.  Additionally, nurses were not communicating the PONV risk score to 
providers.  The purpose of this quality improvement project was to decrease the incidence of 
postoperative nausea and vomiting by fully implementing a PONV risk assessment tool, 
specifically inquiring about a history of motion sickness, and communicating that risk score 
to providers.   
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Clinical Questions 
In scheduled surgical patients (P), how does the use of a risk assessment tool in its 
entirety (I), compared to current practice of not utilizing the entire risk assessment tool (C), 
affect the incidence of postoperative nausea and vomiting (O) within a 6-week time period 
(T)? 
1.  Does adding motion sickness to the prescreening phone calls decrease PONV rates? 
2. Does identifying high risk patients during the prescreening phone call phase decrease 
PONV rates? 
Project Objectives 
• Examine whether the current practice of prescreening questions will need to 
be amended based on the results of this project. 
• Determine if the full risk assessment tool should or should not be 
implemented at the hospital. 
• Improve patient care outcomes by conducting a thorough risk assessment for 
PONV. 
• Improve patient care outcomes by communicating PONV risk scores to 
providers. 
Methodology   
The project used a retrospective pre- and post- implementation quality improvement 
design.  The data for this project was extracted from the electronic health record (EHR) 
where it was documented if the patient experienced nausea and/or vomiting in the post 
anesthesia care unit (PACU). The data extracted during the pre-implementation phase 
provided a baseline of PONV incidence.  After pre implementation data was collected, 
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introduction of the full Apfel Simplifed Risk Score for PONV, including a history of motion 
sickness, was introduced to the staff in the perioperative surgical home department.  
Educational sessions were held for nursing staff regarding the use and implementation of the 
tool.  The post implementation data was extracted similarly to the pre implementation phase. 
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Chapter 2 
The Literature Review will discuss studies and quality improvement projects on 
postoperative nausea and vomiting (PONV) and the use of a risk assessment tool and 
prophylaxis protocol.  Additionally, a theoretical framework will be explored, specifically its 
relation to this quality improvement project.  The review is divided into the following 
sections:  a) terms and concept definitions b) theoretical framework, c) review of literature, 
(d) summary and research gaps, and (e) purpose statement.   
Term/Concept Definitions 
For the purposes of this quality improvement project, postoperative nausea and 
vomiting is defined as nausea and vomiting that occurs within the first 24-hour period after 
surgery (American Society of PeriAnesthesia Nurses [ASPAN], 2006).  Nausea is a self-
report of an unpleasant feeling in the epigastrium or the back of the throat (ASPAN, 2006).  
Some patient descriptors include, but are not limited to “feeling sick to my stomach” and 
“feeling queasy” (ASPAN, 2006).  Vomiting, as defined by ASPAN (2006), is the forceful 
expulsion of the contents of the stomach, duodenum, and jejunum through the oral cavity.  
Prophylaxis is defined as the use of antiemetic medications before the onset of symptoms of 
PONV.  Risk factor refers to an independent predictor of a future occurrence of an event or 
incident (ASPAN, 2006).  Rescue antiemetics are defined as antiemetic medications that are 
used after the onset of nausea and vomiting postoperatively.   
Theoretical Framework  
Postoperative nausea and vomiting can be one’s response to environmental factors 
such as the type of anesthesia used, being a non-smoker, a history of PONV or motion 
sickness, and postoperative opioid use.  Female gender is another risk factor that can lead to 
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PONV.  Neuman Systems Model was used as the theoretical framework because it focused 
on client system wellness and environmental stressors that threaten one’s optimal system 
stability (Fawcett, 2017).  In this quality improvement project, the goal was for the client to 
maintain wellness, despite environmental stressors and one’s response to those stressors.  
Optimal system stability is described as the best possible wellness state of an individual at 
any given time (Neuman & Fawcett, 2011).  Neuman Systems Model is a holistic and 
system-based approach to the person and their response to actual or potential environmental 
stressors (Fawcett, 2017).  There are various components of the systems model.  Prevention 
as Intervention was chosen because it correlates with the risk assessment and prophylaxis 
protocol regarding PONV (Figure 1).  The model has three types of prevention that promote 
wellness: primary, secondary, and tertiary (Neuman & Fawcett, 2011).  Reducing risk factors 
and preventing identified or suspected stressors before the client experiences them, also 
known as retaining wellness, is the first step of Neuman’s model (Zaccagnini & White, 
2017).  Assessing all patients to identify if they may be at risk for PONV will fall under the 
primary type of prevention.  In the secondary prevention phase, the goal is to intervene in 
order to strengthen internal resistance to stressors (Neuman & Fawcett, 2011).  Here, the 
implementation of the prophylactic antiemetics would take place.  Lastly, the tertiary 
prevention phase is defined as the protection of the wellness that was attained from the 
secondary prevention and support the client’s strengths and energy reserves (Neuman & 
Fawcett, 2011).  This phase supports the patient’s wellness they attained from having the 
prophylactic antiemetics and supports the patient during the acute recovery phase. 
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Review of Literature 
 A detailed review of literature was conducted using CINAHL, Google Scholar, and 
MEDLINE.  The key words, or search terms, used included postoperative nausea and 
vomiting, postoperative nausea and vomiting risk assessment, risk of postoperative nausea 
and vomiting, and postoperative nausea and vomiting prophylaxis.  The inclusion criteria 
included the primary language as English, peer reviewed, and published between 2009 and 
2019.  Exclusion criteria were studies that had a narrow focus on specific antiemetic drugs as 
prophylaxis; studies that did not primarily involve PONV; and studies where the patient 
population was primarily pediatric.  A total of 12 articles were selected based on the 
relevance of topic to this literature review.  These articles included literature reviews to 
assess any gaps in research, implementation of quality improvement projects to support and 
provide evidence to the topic, and multivariable analyses to determine the effectiveness of 
risk assessment tools. 
 According to the findings from the articles selected, utilization of a risk assessment 
and prophylactic protocol yielded a number of benefits.  Common findings include a 
decrease in PONV comparing pre-implementation and post-implementation groups, 
identification of risk factors, the use of simplified risk scores, and compliance by anesthesia 
providers of an antiemetic prophylaxis protocol (Tabrizi, Malhotra, Turnbull, & Goode, 
2019; Smith, Haas, Zepp, & Klein, 2016; Thomas, Maple, Norcross, & Muckler, 2019)).   
 When referring to identification of risk factors for PONV, studies showed that various 
factors can lead to PONV, including patients’ gender and age, anesthetics used, and surgical 
variables, such as type of surgery (Kim et al., 2013).  Apfel’s simplified risk score for 
predicting PONV consists of four risk factors: female gender, nonsmoking history, history of 
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PONV or motion sickness, and the use of postoperative opioids.  Female gender is identified 
as a significant risk factor for PONV.  According to Smith & Ruth-Sahd (2016) and Collins 
(2019), females have more than a two and a half times greater chance of experiencing PONV 
regardless of age or menstrual status.  By identifying individuals at high risk for PONV, 
those at low risk can be eliminated from being treated with prophylactic antiemetic therapy 
(Chatterjee, Rudra, & Sengupta, 2011; Apfel et al., 2012).  
 Simplified risk scores have been both reliable and valid in identifying risk factors and 
providing appropriate antiemetics (Pierre & Whelan, 2013).  The most commonly found and 
used risk scores are Apfel’s Simplified Risk Score and Koivuranta Simplified Risk Score.  
Studies have supported the use of the latter scores in that they are simple, containing between 
four and five risk factors, both identifying the higher the score, the higher the risk of PONV 
(Apfel et al., 2012; Smith et al., 2016).  Studies have shown that with the use of the 
simplified risk scores, anesthesia providers can be presented with a PONV risk score 
accompanied with recommendations on the number of prophylactic antiemetics to administer 
based on that individual’s risk (Kappen et al., 2015; smith Merckx, Peuch, Necib, & Pingeon, 
2010).  Because the steps are simplified and recommendations are provided directly to the 
anesthesia provider, compliance of the screening tool and prophylaxis protocol has been 
reached (Tabrizi et al., 2019).  With proper screening and proper administration of 
antiemetics, studies have shown a decrease in PONV and improved patient satisfaction 
(Tabrizi et al., 2019; Smith et al., 2016; Sigaut et al., 2010).  
Summary and Research Gaps 
 Research has proven that with the use of a simplified risk score and prophylactic 
protocol, reduction in PONV is possible and compliance by providers can be achieved.  
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Patients reported a decrease in nausea and vomiting within 24 hours postoperatively, 
showing success in a multitude of studies.  Some noted gaps in research, however, include 
the lack of monitoring and assessing patients for a full 24 hours postoperatively.  Most 
studies evaluated patients in an ambulatory setting, only monitoring their PONV status 
between one and six hours (Smith et al., 2016).  Lastly, studies have been difficult to 
compare due to the various study designs and analyses performed (Thomas et al., 2019).  
Designs, as well as inclusion criteria, differed from study to study.  Kappen et al., (2015) 
recommends to perform a project with the same design, analysis, and inclusion criteria in a 
multi-campus health system as to adequately evaluate and critique the results.  
The purpose of this DNP Project was to evaluate the implementation of a simplified 
risk score and its ability to decrease the incidence of postoperative nausea and vomiting in 
scheduled surgical patients.   
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Chapter 3 
Design 
 This project used a retrospective pre and post implementation quality improvement 
design.  This approach was chosen due to its success in other studies.  Thomas, Maple, 
Norcross, & Muckler (2019) utilized a pre and post implementation design yielding a 
decrease in the incidence of postoperative nausea and vomiting (PONV).  Additionally, 
Smith, Haas, Zepp, & Klein (2016) proved the reduction of PONV in the PACU setting with 
the use of a pre-and post-intervention design.  The data for this project was collected from 
the electronic health record (EHR) where it was documented that the patient experienced 
nausea and/or vomiting in the post anesthesia care unit (PACU).  The data collected during 
the pre-implementation phase provided a baseline of PONV incidence.  The post 
implementation data was extracted similarly to the pre implementation phase.  The pre and 
post implementation data was compared and analyzed.  
Setting 
 The setting for the practice change initiative occurred in a Mid-Atlantic urban, 506 
bed hospital located in central Pennsylvania.  The hospital is part of a large not-for-profit 
healthcare organization that holds Magnet designation for nursing excellence.  
Approximately 12,000 outpatient surgeries occur per year within the organization.  
Participants in the setting were from the operative suite, focusing in the Perioperative 
Surgical Home (where prescreening phone calls occur) and the following three areas where 
participants may receive antiemetics: pre-procedure area, the operating room, and the PACU.  
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Population/Sample 
 Subjects for this project were adult patients undergoing a scheduled surgery.  
Inclusion criteria included English speaking patients 18 years of age and older.  Subjects 
were excluded for the following: pregnancy, admission to the intensive care unit after 
surgery, and mechanical ventilation support overnight after surgery. The sample size for pre 
implementation and post implementation needed to be approximately 350 subjects per group 
to achieve statistical significance using a two-tailed sequential likelihood test.  The factors 
used to determine the sample size were the following: 99% confidence interval, expected 
relative effect size of a 25% reduction in PONV, and a baseline PONV rate of 32% per 
Thomas, Maple, Norcross, & Muckler (2019).  All patients who met the criteria were 
included in the project.   
Data Collection 
Every effort was made to protect the private health information of the subjects.  In 
order to ensure that patient confidentiality was protected, Institutional Review Board (IRB) 
approval through West Chester University and the hospital was obtained and granted from 
both institutions (Appendices A & B).   
All data was de-identified during collection.  Identification numbers were placed on 
documentation forms and stored in a locked cabinet in a secured office in the hospital.  
Informed consent was required, as this was not defined as a research study.   
 The collection of data occurred within the hospital’s existing electronic charting 
system.  The staff documented the presence of nausea and/or vomiting with the assessment 
flowsheet portion of the EHR.  Data was manually extracted regarding the flowsheet rows 
specific to nausea and vomiting documentation. 
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Instruments 
 After pre implementation data was collected, introduction of the Apfel Simplified 
Risk Score for PONV was reviewed with the staff of the perioperative surgical home 
department.  The Apfel Simplified Risk Score for PONV objectively quantifies risks for 
PONV and recommends prophylactic antiemetics based on the patient’s individual risk for 
developing PONV (Thomas et al., 2019).  The risk assessment tool assigns each risk factor 
one point and the cumulative number of points equates to the patient’s individual risk for 
PONV (Thomas et al., 2019).  Risk factors include post-operative opioids, non-smoker, 
female gender, and history of PONV/motion sickness.  Scores are divided into low risk (0-1 
points), moderate risk (2 points), and high risk (3 or more points).  Scores can range from 0-4 
with the corresponding risk for PONV to be 10%, 20%, 40%, 60%, and 80% respectively 
(Thomas et al., 2019).  Additionally, an algorithm links risk severity with treatment 
recommendations.   
Implementation  
The primary investigator educated and supported nursing staff in assessing patients 
for PONV by utilizing the Apfel Simplified Risk Score, specifically focusing on the criteria 
of motion sickness.  Education was provided in staff meetings and during informal 
presentations/inservices to Perioperative Surgical Home (PSH) staff, PACU staff, and 
anesthesia providers.  The primary investigator and selected champions provided live support 
during the implementation of the risk assessment tool.  Registered nurses from the PSH who 
screen patients via the telephone asked patients if they have had a history of motion sickness.  
If the patient answered “yes” to motion sickness, the nurse entered “motion sickness” into the 
patient’s past medical history as well as into a comment box labeled “HPI” (history of 
  
14 
 
present illness) within the patient’s EHR.  A second screening team consisting of two nurse 
practitioners and one anesthesiologist reviewed the patient’s EHR.  If a patient had been 
identified as having motion sickness in the past, the second screening team called the patient 
to inquire about the severity of the motion sickness and any treatments they had used in the 
past to treat it.  The second screening team used their discretion and clinical experience to 
determine if a call to the patient was warranted.  It was not guaranteed the patient would 
receive a call.  The second screening team referred treatment recommendations and orders to 
the primary surgery team.  For patients who screened “yes” for motion sickness, the second 
screening team recorded the patient’s medical record number and date of surgery on a master 
list (Appendix C).  The master list was kept in a purple folder labeled “PONV Screening” 
which was located on the second desk to the left within the Perioperative Surgical Home 
Office.  The primary investigator collected this on a regular basis. 
The primary investigator collected data through a chart review of PONV in English 
speaking, scheduled surgical patients 18 years of age and older within the project timeline.  A 
spreadsheet was utilized to collect and organize patient data (Appendix D).  All identifying 
patient information was de-identified and was included in the data collection.  Each case was 
evaluated for utilization of the Apfel tool, specifically the criteria of motion sickness, the 
patient’s risk score according to the tool, and the incidence of PONV.  Data collection took 
place over a 6-week period. 
Planning/Timeline 
 When planning this project, support for practice change came from key stakeholders.  
The researcher met with the manager of anesthesia services, anesthesia providers, and staff 
nurses in the operative suite to identify the processes that occurred during the practice 
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change.  Throughout the planning process, the primary investigator met with staff during 
staff meetings to educate them on the project and protocol that was implemented.  A timeline 
was shared with staff and key stakeholders providing them with a guide of educational 
sessions, roles of the nurses, roles of anesthesia providers, and dates of implementation (see 
Appendix E). 
Budget 
 The budget for this quality improvement project was minimal.  The primary 
investigator spent under $300 to feed staff members during inservices and educational 
sessions.  There was no direct incurred cost to the hospital.  There was no cost for a 
statistician. 
Data Analysis 
 A categorical two-sample t test was conducted to ensure pre implementation and post 
implementation groups were statistically equivalent.  To identify a change in PONV 
incidence pre/post implementation a two-tailed sequential likelihood test was used. An Alpha 
of 0.05 was used.   
Key Stakeholders 
The main stakeholders of this project included, but were not limited to, patients who 
had a scheduled outpatient surgery, the staff nurses within the PSH, the preoperative suite, 
the operating room and the PACU, providers who worked within the PSH, such as two nurse 
practitioners and one anesthesiologist, anesthesia providers, and hospital leaders who trusted 
staff within the hospital to provide safe and effective care to patients.    
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Plan for Dissemination to Key Stakeholders 
 The primary investigator discussed strengths, weaknesses, opportunities, and results 
of this project with the staff and hospital leadership teams.  A written report and PowerPoint 
presentation was provided to show statistical findings.  Recommendations were made for 
future practice change.   
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Chapter 4 
Results 
This project used a retrospective pre-and post- implementation quality improvement 
design to determine if the use of a risk assessment tool led to a decrease in PONV rates.  Pre-
intervention results were collected between December 23, 2019 and February 2, 2020.  There 
were 12 participants in the pre-intervention group.  Post-intervention results were collected 
between February 3, 2020 and March 15, 2020.  There were 16 participants in the post-
intervention group. 
The null hypothesis was that there was no significant difference in the incidence of 
postoperative nausea and vomiting between pre- and post-intervention of a risk assessment 
tool in scheduled outpatient surgeries.  For the pre-intervention group, 2 of the 12 
participants (17%) experienced PONV.  For the post-intervention group, 3 of the 16 
participants (19%) experienced PONV.   
The pre-intervention group consisted of 6 females and 6 males, and the post-
intervention group consisted of 14 females and 2 males.  Pre-intervention males had a 17% 
incidence of PONV, while zero post-intervention males experienced PONV.  Seventeen 
percent of females in the pre-intervention group experienced PONV and 21% of the females 
in the post intervention group experienced PONV (Table 1).  All participants in the pre-
intervention group received general anesthesia, with 17% experiencing PONV (Table 2).  
Eight percent of those who experienced PONV in the post-intervention group received 
general anesthesia, while 67% of participants who experienced PONV in the post-
intervention group received spinal anesthesia (Table 2). 
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Table 3 shows the distribution of PONV rates by the Apfel risk score. Of the 
participants in the pre-intervention group, 25% of the participants with a risk score of zero 
presented with PONV, and 25% of the participants with a risk score of two also experienced 
PONV.  In the post-intervention group, 20% of the participants with a score of two, 20% 
with a score of three, and 20% with score of four experienced PONV.  
Table 4 summarizes each risk factor for PONV.  Participants may have zero, one or 
multiple risk factors in both the pre and post intervention groups.  In the pre-intervention 
group, 17% of the participants who were female experienced PONV.  In the post-intervention 
group, 21% of the participants who were female experienced PONV.  When referring to the 
risk factor of a history of motion sickness and/or PONV, the pre-intervention group was not 
consistently screened.  One participant had this risk factor, yet no pre-intervention 
participants with this risk factor experienced PONV.  For the post intervention group, all 
participants were screened for a history of motion sickness/PONV, and 20% of them 
experienced PONV.  Fourteen percent of participants in the pre-intervention group and 22% 
in the post intervention group were non-smokers and also experienced PONV.  Lastly, zero 
participants in the pre-intervention group and 11% in the post intervention group who had a 
risk factor for planned postoperative opioids experienced PONV. 
Analysis 
 A two-tailed sequential likelihood test was used to identify a change in PONV 
incidence. The PONV rate was 12.5% higher in the post-intervention group, with a p value of 
0.433.  The p value was greater than the chosen Alpha (0.05), meaning the null hypothesis 
could not be rejected.   
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 A categorical two-sample t test was conducted to ensure pre implementation and post 
implementation groups were statistically equivalent.  The test was used to compare the 
categorical results of the Apfel risk assessment score for pre and post intervention groups.  
The null hypothesis assumed the means were equivalent.  The test results had a mean score 
of 1.3 in the pre-intervention group and a mean score of 2.9 in the post-intervention mean.  
The t test had a p value of 0.001.  The p value was less than Alpha of 0.05, thus rejecting the 
null hypothesis and concluding that the population in the pre-intervention group was different 
than the population in the post intervention group. 
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Chapter 5 
Discussion 
 Postoperative nausea and vomiting causes complications such as delayed healing 
time, increased length of stay, and decreased patient satisfaction (Smith & Ruth-Sahd, 2016).  
Various factors have been identified to increase one’s risk for developing PONV including 
gender, a history of PONV or motion sickness, a history of non-smoking, and the use of 
opioids postoperatively (Squire & Spencer, 2018).  By implementing a risk assessment tool 
to identify risk factors before surgery and treat the patient with appropriate antiemetics, the 
rate of PONV may be decreased.  
 The purpose of this quality improvement project was to evaluate the implementation 
of a simplified risk score and its ability to decrease the incidence of postoperative nausea and 
vomiting in scheduled surgical patients.  The key findings of this project were not ideal.  Due 
to a small sample size and varying populations between the pre and post-intervention groups, 
the rate of PONV did not decrease. 
Although the null hypothesis could not be rejected, this quality improvement project 
did identify clinical significance among the participants who experienced PONV.  Female 
participants experienced PONV more frequently than male participants, a finding supported 
in a study by Squire & Spencer (2018) (Table 1).  Seventeen percent of participants who 
experienced PONV in the pre-intervention group received general anesthesia.  In the post 
intervention group, 67% of those who experienced PONV received spinal anesthesia and 
eight percent received general anesthesia (Table 2).  According to Tabrizi et al. (2019), 
patients tend to experience PONV when volatile anesthetics, such as those used in general 
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anesthesia, are used.  Completing a project in the future with a larger sample size may be 
beneficial to further examine anesthesia types and their correlation to PONV. 
The distribution of PONV rates by the Apfel risk score was difficult to compare 
between the pre and post-intervention groups because participants in the pre-intervention 
group were not consistently screened for motion sickness.  When referring to the Apfel risk 
score, low scores indicate a lower risk for PONV, whereas high scores, such as three or four, 
indicate a higher risk for PONV (Apfel, Laara, Koivuranta, Greim, & Roewer, 1999).  In the 
pre-intervention group, participants with scores of zero and two did experience PONV.  In 
the post intervention group, participants who did experience PONV had scores of two, three, 
and four (Table 3).  Adding motion sickness to the prescreening phone call process did 
identify participants who could be more at risk for PONV; however, it did not lead to an 
increased use of antiemetic mediations preoperatively or an overall decrease in PONV rates 
in this quality improvement project.  When looking at each risk factor of PONV (female 
gender, history of motion sickness/PONV, non-smoker, and planned postoperative use of 
opioids), the quality improvement project was not able to identify statistically significant 
findings (Table 4), though it did identify clinical significance as previously discussed.  
Application of Theoretical Framework 
This project correlates with Neuman Systems Model Prevention as Intervention.  By 
applying the Apfel Risk Assessment to participants during the intervention phase, including 
the risk factor of motion sickness, primary prevention was instituted.  Participants were 
assessed for risk factors and identified for the potential of an increased risk for PONV.  
When the nurses notified providers of the participants’ increased risk for PONV, the 
secondary prevention phase occurred, allowing the providers the opportunity to intervene and 
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promote the use of antiemetics before surgery.  Neuman’s third phase, the tertiary prevention 
phase, supports the wellness of participants’ experience after receiving antiemetics 
prophylactically (Neuman & Fawcett, 2011).  Although participants did not always receive 
antiemetics prophylactically and the incidence of PONV did not decrease, participants’ 
overall wellness was still addressed and antiemetics were administered if PONV did occur.   
Implications for Practice, Education, & Policy  
 This quality improvement project led to implications for both practice and policy 
changes.  Nursing education and possible changes to curriculum were evaluated, though 
implications for changes were not indicated.  Implications for practice include increased 
communication between nursing and anesthesia providers.  Nursing can communicate high 
risk patients (scores of 3 or 4) to the anesthesia providers.  Additionally, implementing a 
prophylaxis protocol that anesthesia providers can utilize can be beneficial.  Once the Apfel 
risk score is identified, providers can tailor the use of antiemetics according to the patient’s 
degree of risk for PONV.   
Possible policy changes include the implementation of a policy on proper PONV 
documentation for nursing staff.  Nursing staff in the perioperative surgical home department 
should be required to ask all patients if he/she has a history of motion sickness.  This will 
allow thorough and non-biased assessment and documentation for PONV for all scheduled 
surgery patients.  Also, a policy can be implemented regarding proper documentation of 
PONV.  There were inconsistencies regarding where within the EHR nurses should 
document PONV.  By instituting a policy, proper documentation can occur, reports can 
accurately be extracted, and data can be appropriately analyzed.   
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Limitations 
 The most notable limitation of this quality improvement project was the small sample 
size.  Data had been extracted manually, but due to a world-wide pandemic and policies of 
strict social distancing, the primary investigator was unable to physically enter the hospital 
and continue to manually collect data.  The primary investigator analyzed the data that was 
collected prior to the pandemic which resulted in a small sample size.  Not having an 
electronic report to collect the data was also a notable limitation for this project.  Manually 
extracting the data was time consuming and limited the number of participants, specifically 
because of the pandemic.  Additionally, the pre and post-intervention groups were not similar 
in population.  The post-intervention group was consistently screened for motion sickness 
and the pre intervention group was not, creating a selection bias.   
 Another limitation that was noted with this quality improvement project included the 
inconsistency of PONV documentation.  Nurses in PACU and on inpatient units were not 
consistently documenting PONV.  Upon review of patients’ EHRs and their medication 
administration records, it was noted that at times antiemetics were administered, yet it was 
not consistently documented that PONV occurred. Additionally, some nurses in the PACU 
were documenting PONV under a gastrointestinal focused assessment, while other nurses 
were documenting it under a nutrition focused assessment.  When the primary investigator 
performed chart reviews to extract data, there were numerous places she needed to look to 
identify if the patient experienced PONV.  
Recommendations 
 A recommendation for future quality improvement projects is to replicate this project, 
but have a larger sample size in order to maximize post-surgical outcomes.  To obtain a 
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larger sample size, the primary investigator should extract and analyze data on all surgical 
patients; not just for those who could manually be extracted.  By creating an electronic report 
that extracts data, the primary investigator can more efficiently and effectively extract and 
analyze data on all surgical patients.  With an increase in sample size, it would be hopeful to 
identify statistically significant findings as well as further validate clinical findings. 
It is recommended to continue to preoperatively screen patients for motion sickness in 
order to further evaluate the effects of the Apfel tool on overall PONV incidence.  Nursing 
can play a more integral role in a future project by regularly screening patients for all PONV 
risk factors and by also consistently documenting and reporting PONV.  Educating staff on 
where to appropriately document PONV within the EHR will provide a more thorough and 
robust project.  Nursing can also advocate for their patients by verbally reporting high-risk 
patients, those with a score of three or four, directly to anesthesia providers.  By verbally 
communicating this to the anesthesia providers, nursing can ensure the providers are aware.  
Nursing can also recommend treatment options, such as the use of a scopolamine patch, an 
antiemetic commonly used to prevent or decrease PONV. 
Additionally, creating a compliance policy for anesthesia providers may benefit 
future studies.  By having anesthesia providers be responsible for following a protocol once 
the Apfel risk score is identified, proper antiemetics can be administered, thus promoting a 
possible decrease in PONV rates.   
Conclusion 
 Postoperative nausea and vomiting is an ongoing complication post-surgery.  With 
the implementation of a risk assessment tool, at risk patients can be identified and 
prophylactically treated.  The outcomes of this project reinforce the need for collaborative 
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care from various members of the healthcare team.  By incorporating nurses and anesthesia 
providers into the thorough assessment of patients and their risk factors, PONV can be more 
closely analyzed and treated. 
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Table 1 
PONV Rates by Gender 
Gender Pre-intervention Post-intervention 
Male 1 (17%, n=6) 0 (0%, n=2) 
Female 1 (17%, n=6) 3 (21%, n=14) 
Total 2  (17%, n=12) 3 (19%, n=16) 
   
Note.  Percentages represent the percentage of participants who experienced PONV. 
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Table 2 
PONV Rates by Anesthesia Type 
Anesthesia Type Pre-intervention Post-intervention 
General 2 (17%, n=12) 1 (8%, n=12) 
Spinal 0 (0%, n=0) 2 (67%, n=3) 
MAC 0 (0%, n=0) 0 (0%, n=1) 
Total 2 (17%, n=12) 3 (19%, n=16) 
   
Note.  Percentages represent the percentage of participants who experienced PONV. 
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Table 3 
PONV Rates by Apfel Risk Score 
Apfel Risk Score Pre-intervention Post-intervention 
0 1 (25%, n=4) 0 (0%, n=0) 
1 0 (0%, n=2) 0 (0%, n=1) 
2 1 (25%, n=4) 1 (20%, n=5) 
3 0 (0%, n=2) 1 (20%, n=5) 
4 0 (0%, n=0) 1 (20%, n=5) 
Total 2 (17%, n=12) 3 (19%, n=16) 
   
Note.  Percentages represent the percentage of participants who experienced PONV. 
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Table 4 
PONV Rates by PONV Risk Factor Predictors 
PONV Risk Factor Predictors Pre-intervention Post-intervention 
Female gender 1 (17%, n=6) 3 (21%, n=14) 
History of motion sickness or 
PONV 0 (0%, n=1) 3 (20%, n=15) 
Nonsmoker 1 (14%, n=7) 2 (22%, n=9) 
Postoperative opioids 0 (0%, n=2) 1 (11%, n=9) 
   
Note.  Percentages represent the percentage of participants who experienced PONV. 
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Figure 1 
 
Figure 1. 
Neuman Systems Model, Prevention as Intervention applied to risk assessment and 
prophylaxis protocol regarding PONV (Neuman & Fawcett, 2011). 
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Appendices 
Appendix A: Institutional Review Board Approval, West Chester University 
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Appendix B: Institutional Review Board Approval, Hospital 
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Appendix C: Master List for Positive Motion Sickness 
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Appendix D: Data Collection Spreadsheet 
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Appendix E: Proposed Timeline 
November 2019-January 2020 
• Researcher will meet with key stakeholders and clinical staff to obtain support 
• Researcher will learn the workflow of the nurses and anesthesia providers in the 
surgical suite 
• Researcher will meet with preceptor to discuss details of the project 
• Submit IRB application to WCU 
• Submit IRB application to proposed hospital site 
• Gather retrospective data (6 weeks-worth) 
• Obtain champions to help implement practice change 
• Educate staff on the practice change and use of the Apfel Risk Assessment Score, 
specifically motion sickness 
 
February 2020 – March 2020 
• Meet with champions to address any barriers 
• Continue educational sessions and inservices regarding implementation 
• Implement the use of the Apfel Risk Assessment Score, specifically motion sickness 
• Gather data and begin interpreting results with a statistician 
• Complete interpretation of results 
April 2020 
• Meet with champions and manager to addresses changes/revisions for future practice 
• Present findings/results to hospital administration  
 
 
